These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2900875)

  • 1. Selective protection of benzomorphan binding sites against inactivation by N-ethylmaleimide. Evidence for kappa-opioid receptors in frog brain.
    Zawilska J; Lajtha A; Borsodi A
    J Neurochem; 1988 Sep; 51(3):736-9. PubMed ID: 2900875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of the binding of [3H]bremazocine in guinea-pig brain: evidence for multiplicity of the kappa-opioid receptors.
    Tiberi M; Magnan J
    Can J Physiol Pharmacol; 1989 Oct; 67(10):1336-44. PubMed ID: 2558788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of N-ethylmaleimide treatment on naloxone binding in frog brain membranes.
    Zawilska J; Lajtha A; Borsodi A
    Acta Biochim Biophys Hung; 1989; 24(1-2):33-9. PubMed ID: 2575315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The occurrence of different kappa opioid receptors (K1 and K2) in frog (Rana esculenta) brain membranes.
    Benyhe S; Varga E; Borsodi A; Wollemann M
    Acta Physiol Hung; 1990; 76(4):291-4. PubMed ID: 1966577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct high-affinity binding sites for benzomorphan drugs and enkephalin in a neuroblastoma--brain hybrid cell line.
    McLawhon RW; West RE; Miller RJ; Dawson G
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4309-13. PubMed ID: 6117074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
    Ensinger HA
    Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of kappa opioid binding using dynorphin A1-13 and U69,593 in the rat brain.
    Devlin T; Shoemaker WJ
    J Pharmacol Exp Ther; 1990 May; 253(2):749-59. PubMed ID: 1971019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation of kappa-opioid receptor subtype from frog brain.
    Simon J; Benyhe S; Borsodi A; Szücs M; Wollemann M
    FEBS Lett; 1985 Apr; 183(2):395-7. PubMed ID: 2985433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites.
    Castanas E; Bourhim N; Giraud P; Boudouresque F; Cantau P; Oliver C
    J Neurochem; 1985 Sep; 45(3):688-99. PubMed ID: 2993510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
    Nock B; Rajpara A; O'Connor LH; Cicero TJ
    Life Sci; 1988; 42(23):2403-12. PubMed ID: 2836684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzomorphan binding sites in rat lumbo-sacral spinal cord.
    Gouardéres C; Audigier Y; Cros J
    Eur J Pharmacol; 1982 Mar; 78(4):483-6. PubMed ID: 6281039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of kappa 1 and kappa 2 opioid binding sites in frog (Rana esculenta) brain membrane preparation.
    Benyhe S; Varga E; Hepp J; Magyar A; Borsodi A; Wollemann M
    Neurochem Res; 1990 Sep; 15(9):899-904. PubMed ID: 2177154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody recognizing kappa- but not mu- and delta-opioid receptors.
    Maderspach K; Németh K; Simon J; Benyhe S; Szücs M; Wollemann M
    J Neurochem; 1991 Jun; 56(6):1897-904. PubMed ID: 1851205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High affinity [3H]ethylketazocine binding: evidence for specific kappa receptors.
    Wood PL; Charleson S
    Neuropharmacology; 1982 Mar; 21(3):215-9. PubMed ID: 6122185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfhydryl groups on opioid receptors revisited. Evidence for two sulfhydryl groups at or near the active site of the mu opioid receptor.
    Ofri D; Simon EJ
    Receptor; 1992; 2(2):109-19. PubMed ID: 1335327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J; Sánchez-Blázquez P; Lee NM
    J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity labelling of frog brain opioid receptors by dynorphin(1-10) chloromethyl ketone.
    Benyhe S; Ketevan A; Simon J; Hepp J; Medzihradszky K; Borsodi A
    Neuropeptides; 1997 Feb; 31(1):52-9. PubMed ID: 9574838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.